247 related articles for article (PubMed ID: 32814771)
21. NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
Wu Q; Zhang H; You S; Xu Z; Liu X; Chen X; Zhang W; Ye J; Li P; Zhou X
Environ Toxicol; 2023 Jul; 38(7):1678-1689. PubMed ID: 37087754
[TBL] [Abstract][Full Text] [Related]
22. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
Cucci MA; Grattarola M; Dianzani C; Damia G; Ricci F; Roetto A; Trotta F; Barrera G; Pizzimenti S
Free Radic Biol Med; 2020 Apr; 150():125-135. PubMed ID: 32101771
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
24. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
25. Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines.
Skowron MA; Niegisch G; Albrecht P; van Koeveringe G; Romano A; Albers P; Schulz WA; Hoffmann MJ
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767070
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
27. IL-1β Promotes Stemness of Tumor Cells by Activating Smad/ID1 Signaling Pathway.
Lu L; Wang P; Zou Y; Zha Z; Huang H; Guan M; Wu Y; Liu G
Int J Med Sci; 2020; 17(9):1257-1268. PubMed ID: 32547321
[No Abstract] [Full Text] [Related]
28. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.
Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X
J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103
[TBL] [Abstract][Full Text] [Related]
29. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
[TBL] [Abstract][Full Text] [Related]
30. Potential inhibitors of RPS6KB2 and NRF2 in head and neck squamous cell carcinoma.
Madhukar G; Subbarao N
J Biomol Struct Dyn; 2024; 42(4):1875-1900. PubMed ID: 37160694
[TBL] [Abstract][Full Text] [Related]
31. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
33. Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.
Riz I; Hawley TS; Marsal JW; Hawley RG
Oncotarget; 2016 Oct; 7(41):66360-66385. PubMed ID: 27626179
[TBL] [Abstract][Full Text] [Related]
34. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.
Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E
Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615
[TBL] [Abstract][Full Text] [Related]
35. TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma.
Chen TM; Huang CM; Hsieh MS; Lin CS; Lee WH; Yeh CT; Liu SC
Aging (Albany NY); 2022 Jun; 14(12):5250-5270. PubMed ID: 35771152
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
Bao LJ; Jaramillo MC; Zhang ZB; Zheng YX; Yao M; Zhang DD; Yi XF
Int J Clin Exp Pathol; 2014; 7(4):1502-13. PubMed ID: 24817946
[TBL] [Abstract][Full Text] [Related]
37. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.
Lu WC; Liu CJ; Tu HF; Chung YT; Yang CC; Kao SY; Chang KW; Lin SC
Oncotarget; 2016 Aug; 7(35):57254-57267. PubMed ID: 27528032
[TBL] [Abstract][Full Text] [Related]
38. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
[TBL] [Abstract][Full Text] [Related]
39. 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.
Lim J; Lee SH; Cho S; Lee IS; Kang BY; Choi HJ
Mol Cells; 2013 Oct; 36(4):340-6. PubMed ID: 24046186
[TBL] [Abstract][Full Text] [Related]
40. Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway.
Shen J; Wang G; Zuo J
Antiviral Res; 2018 Jun; 154():166-173. PubMed ID: 29656059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
